
A lyophilised blend of GHK-Cu, BPC-157 and TB-500, supplied as a single reference preparation for in-vitro comparative research.
GLOW is a combined lyophilised preparation containing three separate research peptides — GHK-Cu, BPC-157 and TB-500 (a synthetic fragment corresponding to a region of thymosin beta-4) — presented together in a single vial. It is supplied for laboratory research where a combined preparation is required, rather than three separately reconstituted compounds.
Each of the three constituents appears independently in preclinical laboratory literature: GHK-Cu in extracellular matrix and fibroblast research, BPC-157 in cytoprotection and angiogenesis research, and TB-500 in actin-binding and cell-migration research. A combined preparation is of interest to research examining more than one of these compounds in parallel. No claim is made about any combined effect, in humans or otherwise.
The information above is provided solely to identify what this compound is and the areas of scientific literature in which it appears. It is not a representation of effect, benefit or outcome, and is not an invitation or recommendation to use this compound in any living subject.
| Presentation | Lyophilised powder in sealed vial |
|---|---|
| Quantity | 70mg — GHK-Cu + BPC-157 + TB-500 |
| Purity testing | Third-party tested for purity and identity; COA available on request |
| Storage | Store sealed, refrigerated and protected from light. Handling and storage are the responsibility of the purchaser. |
| Intended use | Laboratory research use only — not for human or veterinary consumption |
Every batch is submitted for independent third-party analysis to verify purity and identity. The certificate of analysis relates only to the specific batch tested, and speaks only to the purity and identity of that batch. A certificate of analysis is not an indication of safety, suitability or fitness for any purpose, and does not imply approval for use in humans or animals.
🔬 View published lab report — Batch GLO70-0315
To request the COA for your batch, message us on WhatsApp with the batch number printed on the vial.
GLOW is a combined lyophilised preparation containing three separate research peptides — GHK-Cu, BPC-157 and TB-500 (a synthetic fragment corresponding to a region of thymosin beta-4) — presented together in a single vial. It is supplied for laboratory research where a combined preparation is required, rather than three separately reconstituted compounds.
No. GLOW is not a licensed medicinal product and holds no marketing authorisation from the MHRA or any other regulatory body. It has not been evaluated for safety or efficacy in humans. It is supplied strictly as a reference material for laboratory research use only, and must not be administered to any human or animal.
Yes. Every batch is submitted for independent third-party analysis to verify purity and identity. The certificate of analysis for the batch you receive is available on request — message us with your batch number and we will send it over.
No. We do not supply dosing information, administration protocols or usage guidance of any kind, for any compound, under any circumstances. Enquiries seeking such information will not be answered and may result in an order being cancelled and refunded.
Lyophilised compounds are supplied as a dry powder for stability and require a solvent before use in any solution-phase research application. Bacteriostatic water is the standard laboratory solvent for this purpose.
We currently ship within the United Kingdom only. Orders placed before 2pm GMT on a working day are normally dispatched the same day, in plain unbranded packaging with tracking. Purchasers are responsible for ensuring possession and use of these materials is lawful in their jurisdiction.
Important: This product is supplied strictly as a reference material for laboratory research use. It is not for human or veterinary consumption. Do not purchase it if you intend to administer it to yourself, any other person, or any animal. Read our full Research Use Disclaimer.